IDEXX Laboratories Valuation
| IDXX Stock | USD 420.99 0.37 0.09% |
At this time, the firm appears to be fairly valued. IDEXX Laboratories retains a regular Real Value of $409.81 per share. The prevalent price of the firm is $420.99. Our model calculates the value of IDEXX Laboratories from inspecting the firm fundamentals such as Return On Asset of 0.23, return on equity of 0.58, and Operating Margin of 0.27 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting IDEXX Laboratories' valuation include:
Price Book 21.443 | Enterprise Value | Enterprise Value Ebitda 27.4648 | Price Sales 8.777 | Forward PE 35.461 |
Fairly Valued
Today
Please note that IDEXX Laboratories' price fluctuation is very steady at this time. Calculation of the real value of IDEXX Laboratories is based on 3 months time horizon. Increasing IDEXX Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since IDEXX Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IDEXX Stock. However, IDEXX Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 420.99 | Real 409.81 | Target 478.62 | Hype 420.76 | Naive 435.03 |
The intrinsic value of IDEXX Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence IDEXX Laboratories' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of IDEXX Laboratories helps investors to forecast how IDEXX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IDEXX Laboratories more accurately as focusing exclusively on IDEXX Laboratories' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use IDEXX Laboratories' intrinsic value based on its ongoing forecasts of IDEXX Laboratories' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against IDEXX Laboratories' closest peers.
IDEXX Laboratories Cash |
|
IDEXX Valuation Trend
Analysing the historical paterns of IDEXX Laboratories' enterprise value and its market capitalization is a good way to estimate and gauge the value of IDEXX Laboratories over time and is usually enough for investors to make rational market timing decisions.
IDEXX Revenue by Product
IDEXX Laboratories Total Value Analysis
IDEXX Laboratories is currently anticipated to have valuation of 34.91 B with market capitalization of 34.21 B, debt of 265.62 M, and cash on hands of 114.36 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the IDEXX Laboratories fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
34.91 B | 34.21 B | 265.62 M | 114.36 M |
IDEXX Laboratories Investor Information
About 93.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 10.68. IDEXX Laboratories had not issued any dividends in recent years. The entity had 2:1 split on the 16th of June 2015. Based on the key indicators related to IDEXX Laboratories' liquidity, profitability, solvency, and operating efficiency, IDEXX Laboratories is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.3 | 0.2895 |
|
| |||||
| Total Cash From Operating Activities | 975.5 M | 929 M |
|
| |||||
| Operating Income | 1.2 B | 1.1 B |
|
|
IDEXX Laboratories Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. IDEXX Laboratories has an asset utilization ratio of 118.34 percent. This suggests that the Company is making $1.18 for each dollar of assets. An increasing asset utilization means that IDEXX Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.IDEXX Laboratories Ownership Allocation
IDEXX Laboratories has a total of 81.33 Million outstanding shares. The majority of IDEXX Laboratories outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IDEXX Laboratories to benefit from reduced commissions. Thereupon, third-party entities are subject to a different set of regulations than regular investors in IDEXX Laboratories. Please pay attention to any change in the institutional holdings of IDEXX Laboratories as this could imply that something significant has changed or is about to change at the company. On February 13, 2024, Senator Tommy Tuberville of US Senate acquired under $15k worth of IDEXX Laboratories's common stock.IDEXX Laboratories Profitability Analysis
The company reported the previous year's revenue of 3.9 B. Net Income was 887.87 M with profit before overhead, payroll, taxes, and interest of 2.38 B.About IDEXX Laboratories Valuation
Our relative valuation model uses a comparative analysis of IDEXX Laboratories. We calculate exposure to IDEXX Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IDEXX Laboratories's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.4 B | 2.5 B | |
| Pretax Profit Margin | 0.28 | 0.30 | |
| Operating Profit Margin | 0.29 | 0.30 | |
| Net Profit Margin | 0.23 | 0.24 | |
| Gross Profit Margin | 0.61 | 0.61 |
IDEXX Laboratories Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 83.1 M | |
| Quarterly Earnings Growth Y O Y | 0.134 | |
| Forward Price Earnings | 35.461 |
IDEXX Laboratories Current Valuation Indicators
Valuation refers to the process of determining the present value of IDEXX Laboratories and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value IDEXX we look at many different elements of the entity such as IDEXX's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as IDEXX Laboratories, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use IDEXX Laboratories' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes IDEXX Laboratories' worth.Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.